Kolker AE - Search Results

1

Concordance of parapapillary chorioretinal atrophy in ocular hypertension with visual field defects that accompany glaucoma development.

Tezel G, Dorr D, Kolker AE, Wax MB, Kass MA. Tezel G, et al. Among authors: kolker ae. Ophthalmology. 2000 Jun;107(6):1194-9. doi: 10.1016/s0161-6420(00)00114-7. Ophthalmology. 2000. PMID: 10857843

2

Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial.

Kass MA, Gordon MO, Hoff MR, Parkinson JM, Kolker AE, Hart WM Jr, Becker B. Kass MA, et al. Among authors: kolker ae. Arch Ophthalmol. 1989 Nov;107(11):1590-8. doi: 10.1001/archopht.1989.01070020668025. Arch Ophthalmol. 1989. PMID: 2818278 Clinical Trial.

3

Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma.

Lewis JM, Priddy T, Judd J, Gordon MO, Kass MA, Kolker AE, Becker B. Lewis JM, et al. Among authors: kolker ae. Am J Ophthalmol. 1988 Nov 15;106(5):607-12. doi: 10.1016/0002-9394(88)90595-8. Am J Ophthalmol. 1988. PMID: 3189477

4

Trabeculectomy with releasable sutures.

Kolker AE, Kass MA, Rait JL. Kolker AE, et al. Arch Ophthalmol. 1994 Jan;112(1):62-6. doi: 10.1001/archopht.1994.01090130072020. Arch Ophthalmol. 1994. PMID: 8285895

5

Comparative optic disc analysis in normal pressure glaucoma, primary open-angle glaucoma, and ocular hypertension.

Tezel G, Kass MA, Kolker AE, Wax MB. Tezel G, et al. Among authors: kolker ae. Ophthalmology. 1996 Dec;103(12):2105-13. doi: 10.1016/s0161-6420(96)30382-5. Ophthalmology. 1996. PMID: 9003345

6

Parapapillary chorioretinal atrophy in patients with ocular hypertension. I. An evaluation as a predictive factor for the development of glaucomatous damage.

Tezel G, Kolker AE, Kass MA, Wax MB, Gordon M, Siegmund KD. Tezel G, et al. Among authors: kolker ae. Arch Ophthalmol. 1997 Dec;115(12):1503-8. doi: 10.1001/archopht.1997.01100160673001. Arch Ophthalmol. 1997. PMID: 9400782

7

Parapapillary chorioretinal atrophy in patients with ocular hypertension. II. An evaluation of progressive changes.

Tezel G, Kolker AE, Wax MB, Kass MA, Gordon M, Siegmund KD. Tezel G, et al. Among authors: kolker ae. Arch Ophthalmol. 1997 Dec;115(12):1509-14. doi: 10.1001/archopht.1997.01100160679003. Arch Ophthalmol. 1997. PMID: 9400783

8

Clinical factors associated with progression of glaucomatous optic disc damage in treated patients.

Tezel G, Siegmund KD, Trinkaus K, Wax MB, Kass MA, Kolker AE. Tezel G, et al. Among authors: kolker ae. Arch Ophthalmol. 2001 Jun;119(6):813-8. doi: 10.1001/archopht.119.6.813. Arch Ophthalmol. 2001. PMID: 11405831

9

Prognostic factors in glaucomatous visual field loss.

Kass MA, Kolker AE, Becker B. Kass MA, et al. Among authors: kolker ae. Arch Ophthalmol. 1976 Aug;94(8):1274-6. doi: 10.1001/archopht.1976.03910040146002. Arch Ophthalmol. 1976. PMID: 949266

10

Long-term epinephrine therapy of ocular hypertension.

Shin DH, Kolker AE, Kass MA, Kaback MB, Becker B. Shin DH, et al. Among authors: kolker ae. Arch Ophthalmol. 1976 Dec;94(12):2059-60. doi: 10.1001/archopht.1976.03910040719002. Arch Ophthalmol. 1976. PMID: 999550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page